Group One Trading
TNYA icon

Group One Trading’s Tenaya Therapeutics TNYA Stock Holding History

Group One Trading’s Portfolio TNYA Stock Details TNYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-5,200
Closed -$3.7K – 8762
2025
Q4 		$3.7K Buy
+5,200
New +$7.07K ﹤0.01% 7314
2025
Q3 		– Sell
-10,000
Closed -$6.11K – 9161
2025
Q2 		$6.11K Sell
10,000
-7,100
-42% -$3.61K ﹤0.01% 6999
2025
Q1 		$9.75K Buy
17,100
+100
+0.6% +$99 ﹤0.01% 6282
2024
Q4 		$24.3K Buy
+17,000
New +$38.1K ﹤0.01% 5566
2024
Q1 		– Sell
-300
Closed -$972 – 7972
2023
Q4 		$972 Hold
300
– – ﹤0.01% 6991
2023
Q3 		$765 Hold
300
– – ﹤0.01% 7267
2023
Q2 		$1.76K Buy
+300
New +$1.74K ﹤0.01% 7121
2022
Q4 		– Sell
-23,200
Closed -$67K – 8095
2022
Q3 		$67K Buy
+23,200
New +$108K ﹤0.01% 5152

Other funds holding TNYA

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
EAM
Empery Asset Management New York $86.5M AUM
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
BGM
Burkehill Global Management New York $2.77B AUM 65.75% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Group One Trading's TNYA Position: Q2 2026 in Review

Group One Trading sold out of Tenaya Therapeutics (TNYA) in Q2 2026, closing a stake of 22,961 shares — an estimated $17.4K sold.

Group One Trading first reported a position in TNYA in Q3 2022 and held it in 7 quarters. The position peaked at $53K in Q3 2025. 101 funds tracked by Wall St. Rank hold TNYA as of Q2 2026.

  • Group One Trading reported no remaining Tenaya Therapeutics position as of Q2 2026 after selling out during the quarter.
  • Group One Trading sold 22,961 Tenaya Therapeutics shares in Q2 2026, an estimated $17.4K.
  • Group One Trading first reported a position in Tenaya Therapeutics in Q3 2022 and held it in 7 quarters.
  • Group One Trading's Tenaya Therapeutics position peaked at $53K in Q3 2025.
  • 101 funds tracked by Wall St. Rank held Tenaya Therapeutics as of Q2 2026.

Based on Group One Trading's 13F filing for Q2 2026, filed 14 Aug 2026.